What lies ahead in the global psoriasis market?

Drivers include a rising prevalence of the condition and the introduction of emerging therapies.

The dynamics of the global psoriasis market are poised to shift in the coming years to register incremental growth by 2034, according to a DelveInsight report.

The report revealed enhanced investments in spreading disease awareness, direct-to-consumer advertisement, and private and government initiatives drive market growth due to increasing the probability of treatment and compliance.

“The increasingly prevalent pool of psoriasis could be seen as an expansion of the potential market, making it an attractive therapy area to invest in,” DelveInsight said.

Meanwhile, treatment space is expected to significantly impact the market amidst investigating potential therapies for psoriasis treatment.

“Moreover, the anticipated introduction of emerging therapies with improved efficacy and a further improvement in the diagnosis rate is expected to drive the growth of the psoriasis market in the 7MM,” It added.

However, the market also faces barriers impeding further expansion within the forecast period.

Psoriasis treatments pose an economic burden whilst patients with the condition may encounter a lack of curative therapeutic choices, with anti-TNF agents associated with immunogenicity development and notable side effects despite their effectiveness.

DelveInsight noted that the disease is associated with highly fatal complications such as extraintestinal manifestations, toxic megacolon, and colitis-associated colorectal cancer, which require additional medications and treatments, thus leading to higher costs and more complicated psoriasis management.